Cargando…
Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
The human fragment crystallizable (Fc)γ receptor (R) interacts with antigen‐complexed immunoglobulin (Ig)G ligands to both activate and modulate a powerful network of inflammatory host‐protective effector functions that are key to the normal physiology of immune resistance to pathogens. More than 10...
Autores principales: | Chenoweth, Alicia M, Wines, Bruce D, Anania, Jessica C, Mark Hogarth, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228307/ https://www.ncbi.nlm.nih.gov/pubmed/32157732 http://dx.doi.org/10.1111/imcb.12326 |
Ejemplares similares
-
Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities
por: Wang, Lili, et al.
Publicado: (2023) -
Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism
por: Du, Ruixiao, et al.
Publicado: (2022) -
The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
por: Anania, Jessica C., et al.
Publicado: (2019) -
Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2019) -
Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine
por: Yao, Yanfeng, et al.
Publicado: (2019)